The AngioVac System (AngioDynamics, Latham, NY) was developed for the treatment of right-sided heart and intravenous masses. Lately, it has been employed to deal with left-sided heart masses, in particular, native valve endocarditis (NVE) and valve prostheses endocarditis (VPE) in high-risk patients. Left-sided heart endocarditis has a high morbidity, and it also has a high mortality when open heart surgery is performed. Recently, patients presenting with left NVE and VPE have been treated with the off-label use of the AngioVac System even if the solution presents a considerable cerebral embolization risk issue due to the risk of fragmentation rather than a complete en-bloc aspiration of the masses. A percutaneous cerebral embolism protection system is currently used in TAVI procedures, especially when the native valve presents extensive calcifications and consequent significant embolic risks. We hereby present a clinical case series of a combined utilization of the AngioVac System and cerebral embolism protection system Triguard (Keystone Heart Ltd., Herzliya, Israel) to treat left NVE and VPE in prohibitive-surgical-risk patients.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097912 | PMC |
| http://dx.doi.org/10.3389/fcvm.2023.1121488 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Transcatheter mass extraction of left-sided cardiac masses has gained popularity in recent years, with scarce data on effectiveness, safety, and types of devices used. Mostly, left-sided aspirations use mechanical and continuous-flow-mediated devices (the AngioVac [AngioDynamics] and Penumbra systems [Penumbra]). To our knowledge, the use of manual aspiration devices has not been reported yet.
View Article and Find Full Text PDFCardioembolic Stroke Due to Prosthetic Valve Endocarditis Caused by : A Case Report.
Case Rep Infect Dis
November 2024
Department of Internal Medicine, Hamad Medical Corporation, Doha, Qatar.
Article Synopsis
- - A 50-year-old man with a history of double prosthetic valves and uncontrolled diabetes presented with symptoms of a cerebellar stroke, likely due to embolism from prosthetic valve endocarditis (PVE).
- - Diagnosis was complicated and required transesophageal echocardiography (TEE), revealing vegetations on the mitral valve prosthesis; the patient was started on antifungal therapy but faced financial barriers to surgery.
- - Due to persistent infection, the AngioVac system was considered for vegetative aspiration, but ultimately, the patient was discharged with a long-term plan for suppressive antifungal treatment instead of surgery.
Transplanted Heart Complicated by Intracardiac Aspergilloma With Pericardial Involvement.
JACC Case Rep
October 2024
Department of Cardiology, Allegheny General Hospital, Pittsburgh, Pennsylvania, USA.
Article Synopsis
- - The patient, a cardiac transplant recipient, experienced symptoms of right eye pain and blurry vision.
- - Upon investigation, she was diagnosed with intracardiac aspergilloma that affected her pericardium, alongside complications like endogenous endophthalmitis and an acute heart attack.
- - Treatment included a mechanical debulking procedure using the Angiovac system to address the aspergilloma.
Article Synopsis
- Intravascular and intracardiac masses include thrombi, tumors, and vegetations, impacting the heart's chambers and circulation.
- Treatment has traditionally been surgical or involves anticoagulation, but there's a shift towards minimally invasive techniques due to patient complexities.
- The AngioVac System, initially for right-sided heart thrombi, has expanded its use to treat right-sided endocarditis and left-sided masses effectively.
Infective endocarditis (IE) is a bloodstream infection affecting the valves of the heart. IE is highly associated with morbidity and mortality if not properly managed. () as a cause of IE is extremely rare.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!